FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndTotal non-current assets (Million JPY)YoY (%)
Mar 31, 20252,464-3.69%
Mar 31, 20242,558-53.34%
Mar 31, 20235,482-6.83%
Mar 31, 20225,884-8.08%
Mar 31, 20216,401+11.26%
Mar 31, 20205,753-12.56%
Mar 31, 20196,580+3.00%
Mar 31, 20186,388-10.34%
Mar 31, 20177,125-5.09%
Mar 31, 20167,507+148.69%
Mar 31, 20153,019
AI Chat